Literature DB >> 29208442

Defining a global research and policy agenda for betel quid and areca nut.

Hedieh Mehrtash1, Kalina Duncan2, Mark Parascandola2, Annette David3, Ellen R Gritz4, Prakash C Gupta5, Ravi Mehrotra6, Amer Siddiq Amer Nordin7, Paul C Pearlman2, Saman Warnakulasuriya8, Chi-Pang Wen9, Rosnah Binti Zain10, Edward L Trimble2.   

Abstract

Betel quid and areca nut are known risk factors for many oral and oesophageal cancers, and their use is highly prevalent in the Asia-Pacific region. Additionally, betel quid and areca nut are associated with health effects on the cardiovascular, nervous, gastrointestinal, metabolic, respiratory, and reproductive systems. Unlike tobacco, for which the WHO Framework Convention on Tobacco Control provides evidence-based policies for reducing tobacco use, no global policy exists for the control of betel quid and areca nut use. Multidisciplinary research is needed to address this neglected global public health emergency and to mobilise efforts to control betel quid and areca nut use. In addition, future research is needed to advance our understanding of the basic biology, mechanisms, and epidemiology of betel quid and areca nut use, to advance possible prevention and cessation programmes for betel quid and areca nut users, and to design evidence-based screening and early diagnosis programmes to address the growing burden of cancers that are associated with use.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29208442     DOI: 10.1016/S1470-2045(17)30460-6

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  38 in total

1.  Tissue-specific and maturity-dependent distribution of pyridine alkaloids in Areca triandra.

Authors:  Jiao Wu; He Zhang; Shijie Wang; Langxing Yuan; Paul Grünhofer; Lukas Schreiber; Yinglang Wan
Journal:  J Plant Res       Date:  2019-05-24       Impact factor: 2.629

2.  A Unique Partnership Between the University of Hawai'i Cancer Center and the University of Guam: Fifteen Years of Addressing Cancer Health Disparities in Pacific Islanders in Hawai'i and Guam.

Authors:  Hali R Robinett; Rachael T Leon Guerrero; John A Peterson; David C Ward; Neal A Palafox; Carl-Wilhelm Vogel
Journal:  Hawaii J Med Public Health       Date:  2019-06

3.  Areca alkaloids measured from buccal cells using DART-MS serve as accurate biomarkers for areca nut chewing.

Authors:  Adrian A Franke; Laura Biggs; Joanne Y Yew; Jennifer F Lai
Journal:  Drug Test Anal       Date:  2019-04-17       Impact factor: 3.345

4.  Altered Fluorescence of Buccal Cells as a Candidate Biomarker for Areca Nut Chewing.

Authors:  Laura A F Biggs; Adrian A Franke; Christine E Farrar
Journal:  Subst Use Misuse       Date:  2020       Impact factor: 2.164

5.  Introduction to the Special Issue: International Research on Areca Nut and Betel Quid Use.

Authors:  Thaddeus A Herzog; Pallav Pokhrel
Journal:  Subst Use Misuse       Date:  2020       Impact factor: 2.164

6.  Betel Quid, Health, and Addiction.

Authors:  Roger L Papke; Dorothy K Hatsukami; Thaddeus A Herzog
Journal:  Subst Use Misuse       Date:  2020       Impact factor: 2.164

7.  Epidemiology of Head and Neck Squamous Cell Carcinomas: Impact on Staging and Prevention Strategies.

Authors:  Jessica D McDermott; Daniel W Bowles
Journal:  Curr Treat Options Oncol       Date:  2019-04-22

8.  Thinking globally about cancer research on World Cancer Day.

Authors:  Satish Gopal; Sudha Sivaram; Preetha Rajaraman; Edward L Trimble
Journal:  Indian J Med Res       Date:  2020-04       Impact factor: 2.375

Review 9.  Genetic toxicology and toxicokinetics of arecoline and related areca nut compounds: an updated review.

Authors:  Nuno G Oliveira; Daniela L Ramos; Ricardo Jorge Dinis-Oliveira
Journal:  Arch Toxicol       Date:  2020-10-24       Impact factor: 5.153

10.  Association of DSM-5 Betel-Quid Use Disorder With Oral Potentially Malignant Disorder in 6 Betel-Quid Endemic Asian Populations.

Authors:  Chien-Hung Lee; Albert Min-Shan Ko; Frances M Yang; Chung-Chieh Hung; Saman Warnakulasuriya; Salah Osman Ibrahim; Rosnah Binti Zain; Ying-Chin Ko
Journal:  JAMA Psychiatry       Date:  2018-03-01       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.